DPT-IPV

BIOLOGICAL2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Bacterial MeningitisDiphtheriaImmunization; InfectionPertussisPoliomyelitisTetanus

Phase 3

Phase 3 Study of BK1310 in Healthy Infants

CompletedNCT02992925

Tanabe Pharma CorporationImmunization; Infection

Start: 2016-11-30End: 2018-11-30Updated: 2026-01-06

Confirmatory Study of BK1310 in Healthy Infants

CompletedNCT03891758

Tanabe Pharma CorporationBacterial Meningitis, Diphtheria, Pertussis +2

Start: 2019-04-01End: 2020-08-10Updated: 2026-01-06